| # | Drug | Count |
|---|---|---|
| 0 | PREDNISOLONE | 510 |
| 1 | PREDNISOLONE ORAL | 510 |
| 2 | PREDNISOLONE ORAL SOLUTION | 510 |
| 3 | CYCLOPHOSPHAMIDE | 362 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 362 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 362 |
| 6 | METHOTREXATE SODIUM | 352 |
| 7 | INFLIXIMAB | 340 |
| 8 | METHOTREXATE | 337 |
| 9 | RITUXIMAB | 260 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RIMANTADINE HYDROCHLORIDE | 2 | 0.0769 |
| 1 | L-CYSTEINE | 1 | 0.0417 |
| 2 | BISACODYL SUPPOSITORY | 1 | 0.0303 |
| 3 | PENTAMIDINE ISETHIONATE | 24 | 0.0191 |
| 4 | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | 2 | 0.0133 |
| 5 | AURANOFIN | 2 | 0.0098 |
| 6 | DEXRAZOXANE FOR INJECTION | 7 | 0.0074 |
| 7 | METYRAPONE | 7 | 0.0070 |
| 8 | ERYTHROMYCIN LACTOBIONATE | 1 | 0.0068 |
| 9 | OLSALAZINE SODIUM | 1 | 0.0051 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 877 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 493 |
| 2 | Alkylating Drug [EPC] | 425 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 344 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 261 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 178 |
| 6 | Calcineurin Inhibitor Immunosuppressant [EPC] | 156 |
| 7 | Proton Pump Inhibitor [EPC] | 140 |
| 8 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 131 |
| 9 | Sulfonamide Antimicrobial [EPC] | 123 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Adrenal Steroid Synthesis Inhibitor [EPC] | 7 | 0.0070 |
| 1 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 50 | 0.0021 |
| 2 | Protease Inhibitor [EPC] | 87 | 0.0020 |
| 3 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 86 | 0.0017 |
| 4 | Alkylating Drug [EPC] | 425 | 0.0017 |
| 5 | Antimycobacterial [EPC] | 40 | 0.0016 |
| 6 | CD33-directed Immunoconjugate [EPC] | 6 | 0.0016 |
| 7 | Antimalarial [EPC] | 17 | 0.0016 |
| 8 | Antiprotozoal [EPC] | 17 | 0.0016 |
| 9 | Topoisomerase Inhibitor [EPC] | 122 | 0.0016 |